The FDA gave the green light to Bristol Myers Squibb’s much-anticipated schizoph...
Immunai, a biotechnology company based in New York, has partnered with AstraZene...
AbbVie has disclosed that its late-stage monotherapy prospect substantially decr...
Repair Biotechnologies has joined forces with Swiss company Genevant Sciences to...
Biogen and UCB have published a listing of a late-stage clinical trial of dapiro...
Amycretin, Novo Nordisk’s much-anticipated experimental weight-loss drug, was fo...
Vicebio, the British biotech, has closed a $100 million Series B funding round a...
Health technology company PicnicHealth has launched a new product, Virtual Site,...
Results from a mid-stage clinical trial conducted by a small biotechnology compa...
Two medications have been shown to drastically alter the prognosis for the fatal...
Terns Pharmaceuticals’ decision to move away from the liver disease field may tu...
Relay Therapeutics released interim Phase I/II data showing that RLY-2608, its i...
Viridian announced that veligrotug, its potential thyroid eye disease (TED) drug...
Brightflow SAS, a privately owned company at the forefront in the area of long-t...
Genesis Therapeutics’ AI drug discovery platform, GEMS, has gained popularity an...
Eli Lilly’s insulin candidate efsitora alfa has achieved its main goals in a fur...
